Will trade on the Canadian NEO Exchange under the ticker PSYK. The ETF includes companies in the Canadian legal psychedelics industry, as well as U.S. companies engaged in legal activities involving psychedelic drugs and substances. The purpose of the ETF is to "invest in, and indirectly derive revenues from, companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances."
MER = 0.85%
The ETF will include:
-
Johnson & Johnson (JNJ)
-
AbbVie Inc (ABBV)
-
COMPASS Pathways (CMPS)
-
Field Trip Health (FTRP)
-
MindMed (MMED)
-
Greenbrook TMS Inc (GTMS)
-
Entheon Biomedical (ENBI)
-
Seelos Therapeutics (SEEL)
-
Cybin (CYBN)
-
Mind Cure Health (MCUR)
-
Havn Life Sciences (HAVN)
-
Numinus (NUMI)
-
Mydecine Innovations (MYCO)
-
Nova Mentis (NOVA)
-
Psyched Wellness (PSYC)
-
Revive Therapeutics (RVV)
-
Red Light Holland (TRIP)